Bharat Serums and Vaccines Limited (BSV) has agreed to acquire Malaysia’s Firstline Pharmaceuticals Sdn. Bhd and Genomicks Sdn Bhd, for an undisclosed sum. The deal would help bolster BSV’s presence in women’s health and reproductive therapy in Mayalsia.
Following the acquisition, the two companies will be held by BSV.
Firstline Pharmaceuticals is a distributor of fertility treatment in Malaysia, and was incorporated in 2007. Genomicks was incorporated in 2016 and distributes medical devices in Malaysia. The companies distribute a wide range of products, including Foliculin, Hucog, Humog, Profortil, Fortelle+Omega 3.
Rahul Adakmol, BSV Chief Operating Officer (International Operations) said, the accelerations accelerate the company’s business goal of deepening its presence in South-East Asia.
Logen Singam and Chitra Santhirarajan, Founders, Firstline Pharmaceuticals and Genomicks, said in a statement that the association would expand BSV’s presence in women’s health, besides bringing more products for women in Malaysia.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.